Epilepsy genetics: An abundance of riches for biologists  by McNamara, James O. & Puranam, Ram S.
R168 Dispatch
Epilepsy genetics: An abundance of riches for biologists
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Twenty-five genes have been identified in which
mutations cause epileptic seizures in mice. The gene
for a Na+/H+ exchanger has recently been found to
underlie the spontaneous mutant slow wave epilepsy.
Studies of such mutants should help elucidate the
mechanisms that control neuronal excitability.
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Epilepsy, a disorder of brain function characterized by
recurrent seizures, affects roughly 1% of the human popula-
tion. A seizure is a fleeting change in behavior caused by
disordered, synchronized firing of populations of central
nervous system neurons. A seizure may be confined to local-
ized cerebral cortical populations, propagate widely from
such localized populations, or involve widespread cortical
populations from the outset. The behavioral features of a
seizure are determined by which populations of neurons fire
synchronously. The enormous diversity of the epilepsies is
evident in the more than 40 distinct forms that have been
defined in humans [1]. In biblical times, epilepsy was attrib-
uted to possession by evil spirits; even now, the etiology of
epilepsy remains incompletely understood. Genetic deter-
minants have been implicated in at least 35% of individuals
afflicted with epilepsy, but the identity of the mutant genes
that confer susceptibility remain largely unknown.
The mouse is a more tractable species for genetic analysis
than humans, and the rate of progress in elucidating the
genetic basis of inherited epilepsy syndromes in mice has,
in the past three years alone, been astounding. Before
1994, only one gene defect had been linked to cortical
epilepsy in mice; since then, 24 further single-gene muta-
tions have been linked to an epileptic phenotype (Table
1, the genes are mostly listed by the names of their prod-
ucts). Most of these epilepsy genes — 20 out of 25 — have
been identified in mice in which a gene had experimen-
tally been deleted, modified or, less commonly, overex-
pressed. In most instances, the epileptic phenotype came
as a complete surprise to the investigators. Indeed,
epilepsy is arguably the single most common neurological
abnormality recognized in mice with induced mutations. 
In addition to these induced mutations found to cause
epilepsy, a number of spontaneous mutations have been
linked to an epileptic phenotype in mice. In a number of
cases, the genes affected by these spontaneous mutations
have been identified by positional cloning. One example
is slow wave epilepsy (SWE), a recently discovered sponta-
neous mutant that exhibits both ataxia and epileptic
seizures. Cox et al. [2] have recently described the pheno-
type of this mutant mouse, and the results of positional
cloning, which demonstrate that the responsible defect is
a null mutation of the ubiquitously expressed Na+/H+
exchanger, NHE1. This discovery provides a powerful
new tool for elucidating the molecular mechanisms con-
trolling neuronal excitability and selective neuronal
degeneration.
The mouse genes implicated in epilepsy [3,4] encode a
diverse variety of proteins (Table 1), in line with the great
diversity of human epilepsy syndromes. The most
common category of mutations disrupt the function of
chemical synapses, followed by those that affect the
intrinsic excitability of neurons. It is not surprising that
either type of mutation is associated with an epileptic phe-
notype. For example, disruption of synaptic inhibition by
targeted deletion of the gene encoding the γ-amino
butyric acid type A (GABAA) receptor would be expected
to result in increased neuronal excitability. Genes
involved in determining the structural organization of the
nervous system have also been linked to epilepsy, consis-
tent with the common occurrence of epilepsy in humans
with cortical dysgenesis. For many of the remaining genes
listed in Table 1, including the discovery that the SWE
gene encodes a Na+/H+ exchanger, the epileptic mutant
phenotype undoubtedly came as a surprise to the investi-
gators. But such unexpected results are often of consider-
ably greater interest, and more informative, than the
expected ones. 
The discovery that the SWE gene encodes the Na+/H+
exchanger NHE1 opens a rich array of questions of con-
siderable interest to biologists. NHE1 contributes to regu-
lation of intracellular pH and cell volume, as well as
mitogenic responses to growth factors [5]. NHE1 is acti-
vated when the cell is acidified, promoting return of the
intracellular pH to its steady-state level. This protein is
expressed in many organs of the mouse, yet the pheno-
type is restricted to the brain. Might other Na+/H+
exchangers compensate for the absence of NHE1 in other
organs, or does NHE1 have only a trivial contribution to
cellular homeostasis in other organs? 
SWE mice exhibit ataxia (impaired motor control),
presumably because of the degeneration of deep cerebellar
nuclei; neurons in the vestibular and cochlear nuclei also
undergo degeneration in these mutants. Who would have
thought that a deficiency of NHE1 would cause neurons to
degenerate? What is the underlying mechanism? Why does
the degeneration target these neurons in particular, and
spare those elsewhere in the nervous system? Cox et al. [2]
note that the three nuclei undergoing degeneration are
among those with the highest basal metabolic rates [6]. As
one consequence of a high basal metabolic rate — and pre-
sumably a concomitantly high rate of neuronal firing — is a
reduced internal pH [7,8], Cox et al. [2] suggest that
neurons in these nuclei may be particularly dependent
upon NHE1 activity.
How does the absence of NHE1 cause seizures? The
seizures exhibited by the SWE mutants are similar to
absence, or petit mal, seizures in humans, in that they are
characterized by a brief behavioral arrest in association
with a distinctive electroencephalographic abnormality
consisting of 3–4 per second spike-wave discharge. More-
over, the seizures in the SWE mouse and humans with
petit mal epilepsy are both suppressed by the anticonvul-
sant ethosuximide. Absence seizures are caused by the
reciprocal synchronized firing of neurons in the thalamus
and cerebral cortex [9], circuitry that likely subserve phys-
iologic functions of cortical synchronization during sleep.
Many possible mechanisms could account for the
increased excitability of these neurons, as a wide diversity
of neuronal signaling mechanisms are exquisitely sensitive
to pH, including ligand- and voltage-gated ion channels,
intracellular signal transduction pathways and even gap
junctions between neurons.
An interesting possibility suggested by Cox et al. [2] is that
the mechanism of the increased neuronal excitability in
SWE mice is secondary to defective NHE1 activity in the
surrounding astrocytes, rather than in the neurons
themselves. One consequence of this defect in astrocytes
may be reduced H+ transport to the extracellular space,
and a net alkalinization of the extracellular fluid. This
seems to be a plausible mechanism, because hyperventila-
tion —which reduces arterial CO2 content and produces
an alkalosis — reliably triggers absence seizures in
children with the petit mal epilepsy disorder [10].
Apart from these questions of fundamental biological inter-
est, the discovery made by Cox et al. [2] may help elucidate
cellular and molecular mechanisms of absence seizures in
humans. The striking similarities of the seizures in mouse
and man strengthen the likelihood that the defect in the
mouse may somehow provide a clue to genetic defects in
humans with absence seizures. Perhaps a genetic defi-
ciency of NHE1 itself underlies some forms of absence
seizures in humans. Alternatively, perhaps the NHE1
defect will shed light on a signaling cascade that culmi-
nates in increased cortical excitability, and affected
Dispatch R169
Table 1
Mouse genes linked to an epileptic phenotype.
Gene / product Protein type Nature of mutation [Ref]
Synaptic function
Neuropeptide Y Transmitter Targeted deletion [11]
Synapsin 1,2 Transmitter release Targeted deletion [12]
GLT-1 Transmitter transporter Targeted deletion [13]
GABAA β3 Transmitter receptor Targeted deletion [14]
subunit
GABAA δ subunit Transmitter receptor Targeted deletion [15]
GluRB editing Transmitter receptor Transgene with [16]
mutant RNA editing 
deficient allele
5HT2c receptor Transmitter receptor Targeted deletion [17]
Intrinsic excitability of neuron
mKv 1.1 (Shaker) K+ channel Targeted deletion [18]
G protein coupled K+ channel Spontaneous [19]
inward rectifier 
(Weaver)
α1A voltage Ion channel Spontaneous non- [20]
sensitive Ca2+ conservative amino 
channel acid substitution
(Tottering/Leaner)
α1A voltage Ion channel Spontaneous [20]
sensitive Ca2+ splice donor
channel 
(Tottering/Leaner)




Ca2+ calmodulin Protein kinase Targeted deletion [22]
kinase II
Inositol phosphate Receptor for Targeted deletion [23]
3 receptor phospholipid metabolite
Structural organization
Growth Axonal growth cone Overexpression [24]
associated protein
protein (GAP-43)
p35 Neuronal-specific Targeted deletion [25]
activation of cyclin 
kinase (Cdk5)
Otx-1 Homeobox-containing Targeted deletion [26]
gene
Diverse functions
Centromere BP-B DNA binding protein Transgene-induced [27]
insertion
Sphingolipid Protein implicated in Targeted deletion [28]
activator protein lipid metabolism
Tissue nonspecific Enzyme defect results Targeted deletion [29]
alkaline phosphatase in reduced GABA
Slow wave epilepsy Regulator of pH Spontaneous (non- [2]
(Na+/H+ conservative amino
exchanger) acid substitution)
Huntingtin Unknown function Transgene [30]
containing 5′
end of human 
Huntingtin
Protein L-isoaspartate Protein-repair enzyme Targeted deletion [31]
transferase
β-hexosaminidase A Lysosomal enzyme Targeted deletion [32]
Jimpy Proteolipid protein Spontaneous [33]
of myelin splice site
Polyglutamine repeat Unknown Transgene containing [34]
146 unit CAG repeat
inserted in hprt gene
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humans have some defect elsewhere in the cascade.
Although genetic studies of absence seizures in humans
are under way, no genetic defect has been identified as yet.
Mutant mice with phenotypes that involve seizures are
providing biologists with an abundance of riches. Ques-
tions similar to those raised concerning the SWE mutant
are also being asked about many of the other mouse
mutants in which epilepsy is part of the phenotype.
Answers to these questions will teach us valuable lessons
about the genetic control of neuronal excitability in physi-
ologic circumstances. One consequence of this line of
investigation is also likely to be new ways of preventing,
or more effectively controlling, human epilepsies.
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